Search

Bretz et al (2005) proposed multiple Comparison Procedure and Modeling (MCPMod) method to design and analyze dose-finding study. Pinheiro (2014) then generalized it to various types of endpoint, including but not limited to binary endpoint, survival endpoint, count data, and longitudinal data. Pinheiro (2013) recommended to use the estimated covariance matrix from the observed data to recalculate the optimal contrast and the critical value of the test For many phase II studies it is common to have small sample sizes per arm with low placebo response rates jointly. Under such circumstances, it cannot be excluded to have a zero count observed. For example, when the placebo response rate is 10%, there is about 4% chance to observe zero responders in the placebo group, or other dose group(s), which has a similar response rate as placebo. In this manuscript, we would like to illustrate the potential problem of Pinheiro (2013) using a case study and simulations. An alternative method using Firth's logistic regression was evaluated to get a stable estimate of response for each dose group. In addition, we evaluated two options to address the issue with problematic contrast coefficients.

The measurement and analysis of human sex and gender is a nuanced problem with many overlapping considerations including statistical bias, data privacy, and the ethical treatment of study subjects. Traditionally, human gender and sex have been categorized and measured with respect to an artificial binary system. The continuation of this tradition persists mainly because it is easy to replication and not, as we argue, because it produces the most valuable scientific information. Sex and gender identity data is crucial for many applications of statistical analysis and many modern scientists acknowledge the limitations of the current system. However, discrimination against sex and gender minorities poses very real privacy concerns when collecting and distributing gender and sex data. As such, extra thoughtfulness and care is essential to design safe and informative scientific studies. In this paper, we present statistically informed recommendations for the data collection and analysis of human subjects that not only respect each individual's identity and protect their privacy, but also establish standards for collecting higher quality data.